Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.

Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.

Item
http://www.wikidata.org/entity/Q50436282
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertensionBlood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic PatientsBeta-blockers in patients with advanced liver disease: Has the dust settled?Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.Advances in the treatment of portal hypertension in cirrhosis.New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Advances and challenges in cirrhosis and portal hypertension.The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.Prevention and management of gastroesophageal varices.Pharmacologic prevention of variceal bleeding and rebleeding.Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study.Characterization of ascites in cardiac cirrhosis: the value of ascitic fluid protein to screen for concurrent cardiac cirrhosis.The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.
P2860

Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.

Item
http://www.wikidata.org/entity/Q50436282
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Development of hyperdynamic ci ...... osis with portal hypertension.
@en
Development of hyperdynamic ci ...... osis with portal hypertension.
@nl
type
label
Development of hyperdynamic ci ...... osis with portal hypertension.
@en
Development of hyperdynamic ci ...... osis with portal hypertension.
@nl
prefLabel
Development of hyperdynamic ci ...... osis with portal hypertension.
@en
Development of hyperdynamic ci ...... osis with portal hypertension.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Development of hyperdynamic ci ...... hosis with portal hypertension
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698